Editorial: NLRP3 activation and regulation in innate immune responses

Editorial: NLRP3 activation and regulation in innate immune responses

Bibliographic Details
Main Author:	Alessandra Mortellaro
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-03-01
Series:	Frontiers in Immunology
Subjects:	NLRP3 inflammasome pyroptosis chronic inflammation IL-1 (interleukin-1)
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1171138/full

Similar Items

NLRP3 inflammasome: The rising star in cardiovascular diseases
by: Yidan Zheng, et al.
Published: (2022-09-01)

An Epigenetic Insight into NLRP3 Inflammasome Activation in Inflammation-Related Processes
by: Aroa Baragaño Raneros, et al.
Published: (2021-11-01)

Dehydroisohispanolone as a Promising NLRP3 Inhibitor Agent: Bioevaluation and Molecular Docking
by: Laura González-Cofrade, et al.
Published: (2022-07-01)

Chemerin/CMKLR1 Axis Promotes Inflammation and Pyroptosis by Activating NLRP3 Inflammasome in Diabetic Cardiomyopathy Rat
by: Yebin Xie, et al.
Published: (2020-04-01)

NLRP3 inflammasome in metabolic syndrome
by: Fang Wang, et al.
Published: (2021-04-01)

Role of the NLRP3 Inflammasome: Insights Into Cancer Hallmarks
by: Ting-Yi Lin, et al.
Published: (2021-02-01)

Pyroptosis in NLRP3 inflammasome-related atherosclerosis
by: Xiang Zeng, et al.
Published: (2022-10-01)

Role of the NLRP3 Inflammasome in Preeclampsia
by: Koumei Shirasuna, et al.
Published: (2020-02-01)

Regulation and functions of the NLRP3 inflammasome in RNA virus infection
by: Zhaoyang Yue, et al.
Published: (2024-01-01)

NLRP3: a new therapeutic target in alcoholic liver disease
by: Subhashini Brahadeeswaran, et al.
Published: (2023-07-01)

New Insights into the Role of NLRP3 Inflammasome in Pathogenesis and Treatment of Chronic Obstructive Pulmonary Disease
by: Zhang J, et al.
Published: (2021-08-01)

NLRP3 Inflammasome Negatively Regulates RANKL-Induced Osteoclastogenesis of Mouse Bone Marrow Macrophages but Positively Regulates It in the Presence of Lipopolysaccharides
by: Mohammad Ibtehaz Alam, et al.
Published: (2022-05-01)

Mechanistic and therapeutic insights into the function of NLRP3 inflammasome in sterile arthritis
by: Yi Xiao, et al.
Published: (2023-10-01)

Kisspeptin Suppresses Inflammasome-NLRP3 Activation and Pyroptosis Caused by Hypothyroidism at the Maternal-Fetal Interface of Rats
by: Bianca Reis Santos, et al.
Published: (2023-04-01)

NLRP3 Inflammasome Inhibitors in Cardiovascular Diseases
by: Eleonora Mezzaroma, et al.
Published: (2021-02-01)

Icariin alleviates osteoarthritis by inhibiting NLRP3-mediated pyroptosis
by: Yan Zu, et al.
Published: (2019-09-01)

HuNoV Non-Structural Protein P22 Induces Maturation of IL-1β and IL-18 and N-GSDMD-Dependent Pyroptosis through Activating NLRP3 Inflammasome
by: Nini Chen, et al.
Published: (2023-05-01)

Understanding the role of NLRP3-mediated pyroptosis in allergic rhinitis: A review
by: Nuo Cheng, et al.
Published: (2023-09-01)

NLRP3-inflammasome activating DAMPs stimulate an inflammatory response in glia in the absence of priming which contributes to brain inflammation after injury
by: Catherine Diane Savage, et al.
Published: (2012-09-01)

USP50 regulates NLRP3 inflammasome activation in duodenogastric reflux-induced gastric tumorigenesis
by: Chenye Zhao, et al.
Published: (2024-02-01)

Research progress of NLRP3 inflammasome in the pathogenesis of psoriasis
by: Siman SHI, et al.
Published: (2022-10-01)

Juglone Suppresses LPS-induced Inflammatory Responses and NLRP3 Activation in Macrophages
by: Nam-Hun Kim, et al.
Published: (2020-07-01)

Aerobic exercise alleviates pyroptosis-related diseases by regulating NLRP3 inflammasome
by: Shujuan Hu, et al.
Published: (2022-09-01)

A novel dual NLRP1 and NLRP3 inflammasome inhibitor for the treatment of inflammatory diseases
by: Callum AH Docherty, et al.
Published: (2023-01-01)

The Mechanism and Regulation of the NLRP3 Inflammasome during Fibrosis
by: Carol M. Artlett
Published: (2022-04-01)

NLRP3 inflammasome inhibition of OP9 cells enhance therapy for inflammatory bowel disease
by: Yutong Chen, et al.
Published: (2023-07-01)

NLRP3 inflammasome activation contributes to the cognitive decline after cardiac surgery
by: Gang Ma, et al.
Published: (2022-11-01)

Nuclear Receptors as Multiple Regulators of NLRP3 Inflammasome Function
by: Ahmad Alatshan, et al.
Published: (2021-02-01)

LRRC8A is essential for hypotonicity-, but not for DAMP-induced NLRP3 inflammasome activation
by: Jack P Green, et al.
Published: (2020-11-01)

Role of the Nlrp3 Inflammasome in Microbial Infection
by: Paras K Anand, et al.
Published: (2011-02-01)

NLRP3 inflammasome inhibitor OLT1177 suppresses joint inflammation in murine models of acute arthritis
by: Carlo Marchetti, et al.
Published: (2018-08-01)

Suppression of Glucagon-Like Peptide-1 Release by Inhibition of Intestinal NLRP3 Inflammasome Activation in Asc–/– and Nlrp3–/– Mice
by: Yu Chen, et al.
Published: (2019-10-01)

The NLRP3 Inflammasome and Its Role in the Pathogenicity of Leukemia
by: Laura Urwanisch, et al.
Published: (2021-01-01)

Inhibition of IL1R1 or CASP4 attenuates spinal cord injury through ameliorating NLRP3 inflammasome-induced pyroptosis
by: Chenfeng Wang, et al.
Published: (2022-08-01)

Cystatin C Deficiency Increases LPS-Induced Sepsis and NLRP3 Inflammasome Activation in Mice
by: Monika Biasizzo, et al.
Published: (2021-08-01)

Neuroprotection of Emodin by Inhibition of Microglial NLRP3 Inflammasome-Mediated Pyroptosis
by: Wen Jiang, et al.
Published: (2023-03-01)

Airborne particulate matter (PM2.5) triggers cornea inflammation and pyroptosis via NLRP3 activation
by: Liangliang Niu, et al.
Published: (2021-01-01)

The important role of NLRP6 inflammasome in Pasteurella multocida infection
by: Xingping Wu, et al.
Published: (2022-10-01)

Unraveling the Role of the NLRP3 Inflammasome in Lymphoma: Implications in Pathogenesis and Therapeutic Strategies
by: Ioanna E. Stergiou, et al.
Published: (2024-02-01)

NLRP3 Inflammasome/Pyroptosis: A Key Driving Force in Diabetic Cardiomyopathy
by: Lixia Zhang, et al.
Published: (2022-09-01)